Wegovy Injection Amounts: Complete Dosing Guide From a Prescribing Physician

Wegovy Injection Amounts: Complete Dosing Guide From a Prescribing Physician

By Dr. Onikepe Adegbola, MD PhD

Wegovy uses a five-step dose escalation that takes 16 weeks before you reach the full maintenance dose. Every step exists for a reason, and understanding the specific Wegovy injection amounts at each stage helps you anticipate what's coming — both in terms of efficacy and side effects.

I prescribe Wegovy regularly, and the questions I get about injection amounts are remarkably consistent. How much am I actually injecting? Why can't I start at the full dose? What if I'm losing weight at a lower dose — do I still need to go up? Let me walk through the specifics.

The Five Wegovy Injection Amounts: Week-by-Week Breakdown

Wegovy (semaglutide 2.4 mg) is FDA-approved for chronic weight management in adults with BMI ≥ 30, or BMI ≥ 27 with at least one weight-related condition. The drug is identical to Ozempic's active ingredient — semaglutide — but at a higher target dose specifically studied for weight loss.

Weeks 1–4: 0.25 mg (Initiation)

The lowest Wegovy injection amount is 0.25 mg weekly. This dose is subtherapeutic for weight loss. Its entire purpose is gastrointestinal priming — letting your gut, pancreas, and central appetite circuits adjust to GLP-1 receptor agonism before you ramp up.

Most patients report minimal appetite changes at 0.25 mg. You might notice slightly reduced hunger toward the end of the month, but significant weight loss at this dose is uncommon. Don't be discouraged. This is the seatbelt-fastening phase.

Weeks 5–8: 0.5 mg (Early Escalation)

Doubling to 0.5 mg is where many patients first notice the medication working. Appetite suppression becomes more apparent. Some patients describe eating half of what they normally would and feeling genuinely satisfied. Early GI side effects — nausea, mild abdominal discomfort, occasional constipation — tend to peak during this transition.

In the STEP clinical trials, meaningful weight loss trajectories typically began at the 0.5 mg dose level, though the slope accelerates significantly at higher Wegovy injection amounts.

Weeks 9–12: 1.0 mg (Mid-Escalation)

The 1.0 mg dose is equivalent to the maximum approved Ozempic dose for type 2 diabetes. For weight management specifically, this is still a stepping stone. Patients who have been on Ozempic 1.0 mg and switch to Wegovy will recognize this level — the difference is that Wegovy keeps climbing.

At 1.0 mg, most patients are experiencing consistent appetite reduction and measurable weight loss. GI side effects from the previous escalation have usually settled. The body is adapting.

Weeks 13–16: 1.7 mg (Late Escalation)

This is the dose where Wegovy begins to separate from Ozempic in clinical experience. The 1.7 mg injection amount pushes semaglutide exposure beyond what's available in the diabetes indication. Appetite suppression deepens. Weight loss accelerates.

Some patients experience a second wave of nausea at this dose level. It's less common than the initial escalation nausea, but when it occurs, it can be more intense. In my practice, this is the point where I most frequently recommend slowing down — extending the 1.7 mg phase to 6 or 8 weeks before moving to the final dose.

Week 17 Onward: 2.4 mg (Maintenance)

The full Wegovy injection amount of 2.4 mg weekly is the target maintenance dose. This is the dose studied in the STEP trials that produced average weight loss of 15–17% of body weight over 68 weeks. Some patients lose considerably more; others plateau at 10–12%. Individual variation is substantial and depends on factors including starting BMI, dietary adherence, physical activity level, and genetic differences in GLP-1 receptor sensitivity.

Once at 2.4 mg, you stay there indefinitely — or until you and your prescriber decide to adjust. There is no further escalation. If 2.4 mg isn't producing adequate weight loss after several months at the full dose, the conversation shifts to combination strategies rather than higher semaglutide doses.

One point I emphasize with patients reaching the maintenance Wegovy injection amount: this is where nutritional strategy becomes most important. You'll be eating significantly less for a prolonged period. The acute adjustment phase is over, but the chronic nutritional demands are just beginning. Ensuring adequate protein, vitamins, and minerals at this stage determines whether you feel energized or depleted six months from now.

How the Autoinjector Pens Work

Each Wegovy injection amount comes in a dedicated, color-coded, single-use autoinjector pen. You cannot dial a dose. You cannot use a 2.4 mg pen to inject a 1.0 mg dose. Each pen delivers its fixed amount when you press the button against your skin.

The pens are designed for subcutaneous injection into the abdomen, thigh, or upper arm. Rotate injection sites weekly to avoid lipodystrophy (changes in fat tissue at the injection site). The injection itself is quick — most patients describe a brief pinch lasting 5–10 seconds.

Pen colors correspond to dose strengths, and your pharmacy will dispense the correct strength based on where you are in the escalation schedule. If your prescription refill arrives with a different color than expected, verify with your pharmacist before injecting.

Why You Can't Skip Straight to the 2.4 mg Dose

Patients frequently ask why the escalation takes four months. The logic is straightforward: semaglutide at full dose hits the GI tract hard if introduced without preparation.

GLP-1 receptor agonists slow gastric emptying, reduce appetite centrally, and alter pancreatic hormone secretion. Introducing these effects gradually gives the body time to establish a new equilibrium at each level. Skip to 2.4 mg on day one, and you're likely looking at severe nausea, vomiting, and potentially dehydration — which can cause acute kidney injury in vulnerable patients.

The 4-week intervals at each Wegovy injection amount were validated in the STEP trials as the minimum safe escalation timeline. Your prescriber can extend any step; they should not shorten them.

Managing the Transition Between Wegovy Injection Amounts

Each dose increase brings a transient adjustment period. Here's what consistently helps my patients navigate these transitions:

• Eat smaller meals: Your stomach is emptying more slowly. Large meals sit there. Small, frequent meals digest more comfortably
• Prioritize protein: Reduced caloric intake makes every bite count. Protein preserves lean muscle mass and stabilizes blood sugar between meals
• Hydrate aggressively: GI side effects cause subtle fluid losses. Aim for 64+ ounces of water daily, more if you're experiencing nausea or diarrhea
• Don't lie down immediately after eating: Delayed gastric emptying plus a recumbent position is a recipe for reflux and nausea
• Support your gut: Digestive enzyme supplementation and probiotics help the GI tract process food efficiently when motility is slowed

Nutritional support during dose escalation is not optional — it's strategic. Patients on GLP-1 medications eat significantly less, which means fewer opportunities to get essential vitamins, minerals, and protein. Casa de Sante GLP-1 supplements are specifically formulated for this exact scenario — low-FODMAP, gut-gentle products designed by a physician who understands the pharmacology these patients are navigating.

Frequently Asked Questions About Wegovy Injection Amounts

Can I stay at a lower Wegovy dose if I'm already losing weight?

Yes. If you're achieving meaningful weight loss at 1.0 mg or 1.7 mg with tolerable side effects, there's no clinical mandate to escalate to 2.4 mg. The maintenance dose was the target studied in trials, but individual dose optimization is appropriate. Discuss with your prescriber.

What if I miss a Wegovy injection?

If less than 5 days have passed since the missed dose, take it as soon as possible and resume your regular weekly schedule. If more than 5 days have passed, skip the missed dose and take the next one on your regular day. Do not inject two doses within 2 days of each other.

Are the Wegovy injection amounts the same as Ozempic?

No. Ozempic is available in 0.25 mg, 0.5 mg, 1.0 mg, and 2.0 mg doses. Wegovy goes up to 2.4 mg. The drugs contain identical semaglutide, but the dosing schedules and approved indications differ. Ozempic is approved for type 2 diabetes; Wegovy is approved for chronic weight management.

Does the injection site affect how much medication I absorb?

Absorption is consistent across recommended injection sites (abdomen, thigh, upper arm) for subcutaneous delivery. Site selection should be based on comfort and rotation rather than pharmacokinetic concerns.

How long do I stay on Wegovy?

Current evidence suggests that weight regain occurs in most patients after discontinuation. The STEP 1 extension trial showed that patients who stopped semaglutide regained approximately two-thirds of lost weight within one year. For most patients, Wegovy is a long-term or indefinite therapy. This makes managing side effects and nutritional status at your maintenance Wegovy injection amount all the more important.